Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2018 · 6.6K citations · Full text

Medicine, Oncology, Pharmacology +16

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova et al. · Molecular Cancer Therapeutics · 2017 · 2.4K citations · Full text

Medicine, Immunology, Oncology +17

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Syed Mahmood, Michael G. Fradley, Justine V. Cohen et al. · Journal of the American College of Cardiology · 2018 · 1.5K citations · Full text

Life Sciences, Immunology, Internal Medicine +12

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Jennifer L. McQuade, Carrie R. Daniel, Kenneth R. Hess et al. · The Lancet Oncology · 2018 · 658 citations · Full text

Medicine, Dermatology, Oncology +14